InnoBio Fund
14
16M
11
1
0.21
8
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Maisons-alfort. The company was established in Europe in France.
Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight DBV Technologies, Poxel, Millendo Therapeutics. Among the most popular fund investment industries, there are Therapeutics, Pharmaceutical. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - France.
The usual things for fund are deals in the range of 10 - 50 millions dollars. This InnoBio Fund works on 41 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The important activity for fund was in 2010.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the InnoBio Fund, startups are often financed by Sofinnova Partners, OUP (Osage University Partners), Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Andera Partners, Omnes Capital, Amundi Private Equity Funds. In the next rounds fund is usually obtained by Andera Partners, Kreos Capital, Bpifrance.
Investments analytics
Analytics
- Total investments
- 14
- Lead investments
- 1
- Exits
- 8
- Follow on index
- 0.21
- Investments by industry
- Biotechnology (13)
- Therapeutics (8)
- Pharmaceutical (6)
- Health Diagnostics (3)
- Life Science (3) Show 7 more
- Investments by region
-
- France (13)
- United States (1)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 7M
- Group Appearance index
- 0.93
- Avg. company exit year
- 16
- Avg. multiplicator
- 0.83
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AlgoTherapeutix | 14 Mar 2023 | Biotechnology, Information Technology, Pharmaceutical | Early Stage Venture | 23M | Ile-de-France, Suresnes, France |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.